Cryptococcus gattii in the united states: Clinical aspects of infection with an emerging pathogen

Clinical Infectious Diseases

Volumn 53, Issue 12, 2011, Pages 1188-1195

  Harris, J R ^a   Lockhart, S R ^a   Debess, E ^b   Marsden Haug, N ^c   Goldoft, M ^c   Wohrle, R ^c   Lee, S ^d   Smelser, C ^e   Park, B ^a   Chiller, T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Oregon Department of Public Health   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e NEW MEXICO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CRYPTOCOCCUS GATTII; DEATH; DISEASE COURSE; EPIDEMIC; FEMALE; GENOTYPE; HUMAN; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; NORTHWESTERN UNITED STATES; RISK FACTORS; YOUNG ADULT;

EID: 81855211501     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir723     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention (CDC). Emergence of Cryptococcus gattii-Pacific Northwest, 2004-2010. MMWR Morb Mortal Wkly Rep 2010; 59:865-8.
2. MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007; 13:42-50. (Pubitemid 46057836)
3. Galanis E, Macdougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis 2010; 16:251-7.
4. Datta K, Bartlett KH, Baer R, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009; 15:1185-91.
5. Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis 2010; 16:14-20.
6. Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 2008; 25:S4-12. (Pubitemid 351518336)
7. Byrnes E Jr, Bildfell R, Frank SA, Mitchell TG, Marr K, Heitman J. Molecular evidence that the Vancouver Island Cryptococcus gattii outbreak has expanded into the United States Pacific Northwest. J Infect Dis 2009; 199:1081-6.
8. Kidd SE, Guo H, Bartlett KH, Xu J, Kronstad JW. Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot Cell 2005; 4:1629-38. (Pubitemid 41484222)
9. Kidd SE, Hagen F, Tscharke RL, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258-63. (Pubitemid 39627807)
10. Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host-and varietydependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000; 31:499-508. (Pubitemid 32289583)
11. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-30. (Pubitemid 14076734)
12. Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20:611-6.
13. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39:155-68. (Pubitemid 32377312)
14. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21:28-34. discussion 5-6.
15. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9:189-95. (Pubitemid 36231789)
16. Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa. J Infect Dis 2005; 192:888-92. (Pubitemid 41193087)
17. Escandon P, Sanchez A, Martinez M, Meyer W, Castaneda E. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res 2006; 6:625-35. (Pubitemid 43725747)
18. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 2005; 11:1686-92. (Pubitemid 41628346)
19. Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A 1984; 257:213-8. (Pubitemid 14001263)
20. Byrnes E, Li W, Lewit Y, et al. Examination of Cryptococcus gattii isolates from HIV/AIDS patients uncovers a diverse population of VGIII molecular type isolates endemic in southern California. Vancouver, Canada: Infectious Diseases Society of America, 2010.
21. Byrnes EJ 3rd, Li W, Lewit Y, et al. First reported case of Cryptococcus gattii in the southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLoS One 2009; 4:e5851.
22. Upton A, Fraser JA, Kidd SE, et al. First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J Clin Microbiol 2007; 45:3086-8. (Pubitemid 47417362)
23. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (sero types A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15:535-7. (Pubitemid 12178899)
24. Iqbal N, DeBess EE, Wohrle R, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010; 48:539-44.
25. Meyer W, Aanensen DM, Boekhout T, et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47:561-70.
26. Kwon-Chung KJ. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 1976; 68:943-6.
27. Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 2009; 199:1081-6.
28. Byrnes EJ 3rd, Li W, Lewit Y, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6:e1000850.
29. Chen SC. Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother 2002; 49(Suppl 1):57-61. (Pubitemid 34162659)
30. Lizarazo J, Linares M, de Bedout C, Restrepo A, Agudelo CI, Castaneda E. [Results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997-2005]. Biomedica 2007; 27:94-109. (Pubitemid 351836112)
31. Lopez-Martinez R, Soto-Hernandez JL, Ostrosky-Zeichner L, Castanon-Olivares LR, Angeles-Morales V, Sotelo J. Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia 1996; 134:61-4. (Pubitemid 27015479)
32. The World Factbook: United States. 2010. Available at: https://www.cia.gov/library/publications/the-world-factbook/geos/us.html. Accessed 31 October 2010.
33. Brandt ME, Hutwagner LC, Klug LA, et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J Clin Microbiol 1996; 34:912-7. (Pubitemid 26091506)